• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Deals

Gene Therapy of treatment and adjustment of DNA
Manufacturing

Acuitas takes majority stake in Montreal-based RNA manufacturer

Acuitas Therapeutics shelled out an undisclosed sum to acquire a majority stake in Montreal-based RNA Technologies & Therapeutics.
Joseph Keenan Jan 8, 2026 9:12am
research deal two people shaking hands in lab

AstraZeneca extends Niowave radioisotope supply deal by 10 years

Dec 23, 2025 7:47am
Ramaswamy
Favicon Fierce Biotech

Ramaswamy-backed Ambros launches with $125M to develop pain med

Dec 16, 2025 1:32pm
deal handshake business cooperation partnerships

Microsize buys Lonza micronization plant for undisclosed price

Dec 1, 2025 11:45am
stack of letters mail envelopes
Favicon Fierce Biotech

Pfizer finalizes Metsera buy after contentious Novo bidding war

Nov 13, 2025 12:43pm
Pfizer
Favicon Fierce Biotech

Pfizer beats out Novo with $10B agreement to buy Metsera

Nov 8, 2025 8:11am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings